This study cohort included 176 ovarian cancer patients, 109 women without cancer but with known BRCA1 mutations, and 295 healthy controls from the United Kingdom, Italy, Germany, Norway, and the Czech Republic. The gene discussed is BRCA1; the disease is ovarian cancer.